Efficacy of routine follow-up in patients with recurrent uterine cancer

Gynecologic Oncology

Volumn 107, Issue 1, 2007, Pages 124-129

  Smith, Christopher J ^a   Heeren, Monique ^a   Nicklin, James L ^a   Perrin, Lewis C ^a   Land, Russell ^a   Crandon, Alex J ^a   Obermair, Andreas ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Recurrence; Uterine cancer; Vaginal vault cytology

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CENSORSHIP; CLINICAL FEATURE; CYTOLOGY; DEATH; ENDOMETRIOID CARCINOMA; FEMALE; FOLLOW UP; HEALTH EDUCATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMAGING; LOG RANK TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; UTERUS CANCER; VAGINA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; UTERINE NEOPLASMS;

EID: 34648817404     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.06.002     Document Type: Article

References (12)

1. AIHW (Australian Institute of Health and Welfare) and AACR (Australasian Association of Cancer Registries). AIHW National Mortality Database, Australia's Health; 2004.
2. Kitchener H. Management of endometrial cancer. Eur. J. Surg. Oncol. 32 8 (2006) 838-843
3. American Cancer Society. Cancer Facts and Figures 2007 (2007), American Cancer Society, Atlanta
4. Creutzberg C., Van Putten W., Koper P., et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol. Oncol. 89 (2003) 201-209
5. Fung-Kee-Fung M., Dodge J., Elit L., Lukka H., Chambers A., and Oliver T. Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol. Oncol. 101 (2006) 520-529
6. Tjalma W., Van Dam P., Makar A., and Cruickshank D. The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. Int. J. Gynecol. Cancer 14 (2004) 931-937
7. Agboola O., Grunfeld E., Coyle D., and Perry GA. Cost and benefits of routine follow-up after curative treatment for endometrial cancer. Can. Med. Assoc. J. 157 (1997) 879-886
8. Morice P., Levy-Piedbois C., Ajaj S., Pautier P., Haie-Meder C., Lhomme C., et al. Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur. J. Cancer 37 (2001) 985-990
9. Bristow R., Purinton S., Santillan A., Diaz-Montes T., Gardner G., and Giuntoli II R. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol. Oncol. 103 2 (2006) 709-713
10. Olaitan A., Murdoch J., Anderson R., James J., Graham J., and Barley V.A. Critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study. Int. J. Gynecol. Cancer 11 (2001) 349-353
11. Cooper A.L., Dornfeld-Finke J.M., Banks H.W., Davey D.D., and Modesitt S.C. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?. Obstet. Gynecol. 107 1 (2006) 71-76
12. Bradley E., Calvert E., Pitts M., and Redman C. Illness Identity and the self-regulatory model in recovery from early stage gynecological cancer. J. Health Psychol. 6 (2001) 511-521